Journals / Türk Kardiyoloji Derneği Arşivi / 2004 / Cilt: 32 - Sayı: 1

The role of angiotensin converting enzyme gene polymorphism in the development of premature coronary artery disease

Anjiyotensin dönüştürücü enzim gen polimorfizminin erken koroner arter hastalığı gelişimindeki rolü

Pages
23–27
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: ACE gene polymorphism does not seem to be associated with premature coronary artery disease in the studied, limited-sized Turkish sample population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Angiotensin-converting enzyme (ACE) gene polymorphism has been associated with many cardiovascular pathologies.
📊
Key Findings & Data:A total of 139 young patients (?50 years) with coronary artery disease were evaluated in regard to ACE gene polymorphism and conventional coronary risk factors.
💡
Conclusion & Impact:Conclusion: ACE gene polymorphism does not seem to be associated with premature coronary artery disease in the studied, limited-sized Turkish sample population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Angiotensin-converting enzyme (ACE) gene polymorphism has been associated with many cardiovascular pathologies. The goal of our study was to assess the association of ACE gene polymorphism with premature coronary artery disease in Turkish population sample. A total of 139 young patients (?50 years) with coronary artery disease were evaluated in regard to ACE gene polymorphism and conventional coronary risk factors. The findings were analyzed and compared with those of 67 healthy young persons. Both allele frequencies and ACE genotype distribution did not differ substantially between groups (ACE I/I: %13.7; ACE I/D: %59; ACE D/D: %27.3 in the study group and; ACE I/I: %17.9, ACE I/D: %57.2, ACE D/D: %27.9 and in the control group). The odds ratios were 0.88 for D homozygotes (p > 0.05) and 1.03 for the D allele (p > 0.05). On the other hand, the other variables (smoking, plasma cholesterol level, obesity, and diabetes mellitus) were found to be related to the development of premature coronary artery disease. Conclusion: ACE gene polymorphism does not seem to be associated with premature coronary artery disease in the studied, limited-sized Turkish sample population.

Özet

Anjiyotensin dönüştürücü enzim (ACE) gen polimorfizminin çeşitli kardiyovasküler patolojilere olan etkisi tartışılmaktadır. Biz de çalışmamızda bu genetik faktörün Türk toplumunda erken koroner arter hastalığı gelişimi üzerine etkisini araştırmayı amaçladık. Koroner arter hastalığı tespit edilmiş 50 yaş ve daha altındaki 139 olgunun konvansiyonel risk faktörleri ve ACE genotip dağılımları, aynı yaş grubundaki koroner arter hastalığı tespit edilmeyen 67 olguyla karşılaştırıldı. Erken koroner arter hastalığı tespit edilen ve edilmeyen her iki gruptaki ACE genotip dağılımı benzer şekildeydi. (Çalışma grubunda ACE I/I: %13.7; ACE I/D: %59; ACE D/D: %27.3; kontrol grubunda ACE I/I: %17.9, ACE I/D: %57.2, ACE D/D: %27.9). ACE D/D genotipinin erken koroner arter hastalığı relatif risk oranı 0.88 (p > 0. 05) ve D alelinin relatif risk oranı 1.03 (p > 0.05) bulundu. Buna karşın total kolesterol seviyesi, HDL kollesterol seviyesi, LDL kolesterol seviyesi, sigara kullanımı, vücut kitle indeksi ve diabet sıklığı erken koroner arter hastalığı tespit edilen grupta istatistiksel anlamlı şekilde farklı bulundu. Sonuç: Sınırlı bir örnekleme dayanan gözleme göre, ACE gen polimorfizmi Türk toplumunda erken koroner arter hastalığı gelişiminde rol oynayan bir faktör olarak görünmemektedir.

🔖

Cite This Article

DAYİ, Ş. Ü., AKBULUT, T., TERZİ, S., AYDIN, A., BAĞIRTAN, B., PEKER, İ., BİLSEL, T., UYAREL, H., SAYAR, N., YEŞİLÇİMEN, K., ÇİLOĞLU, F. (2022). The role of angiotensin converting enzyme gene polymorphism in the development of premature coronary artery disease. Türk Kardiyoloji Derneği Arşivi, Cilt: 32 - Sayı: 1, 23–27. https://ajindex.com/articles/633819

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. New Engl J Med 1987
  2. 35 2. The SOLVD Investigators: Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991
  3. 302 3. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting enzyme inhibitor, ramipril on cardiovascular events in high risk patients. N Engl J Med 2000
  4. 53 4. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993
  5. 8 5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990
  6. 6 6. Danser AH, Schalekamp M, Bax WA, et al: Angiotensin-converting enzyme in the human heart. Effect of the Deletion/Insertion polymorphism. Circulation 1995
  7. 8 7. Nakahara K, Matsushita S, Matsuoka H, et al: Insertion/Deletion polymorphism in the angiotensin-converting enzyme gene affects heart weight. Circulation 2000
  8. 56 8. Schunkert H, Hense H-W, Holmer SR, et al: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994
  9. 8 9. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994
  10. 8 10. Juenemaitre X, Lifton RP, Hunt SC, et al: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992
  11. 5 11. Bostan C, Karcıer S: Anjiyotensin dönüştürücü enzim geni polimorfizmi ve kardiyovasküler hastalıklar. Türk Kard Dern Arş 2002
  12. 8 12. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992
  13. 4 13. Raynolds MV, Bristow MR, Bush EW, et al: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993
  14. 5 14. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmud PJ, McKenna WJ: Lack of association between